Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MA 02 - Emerging Targets
- 11:00 - 12:30
- 10/16/2017
- Location: Room 511 + 512
- Type: Mini Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Ravi Salgia, Shun Lu
-
+
MA 02.11 - A Phase I Trial of Erlotinib and Onalespib in EGFR-mutant NSCLC: Focus on EGFR Exon 20 Insertions
12:10 - 12:15 | Presenter: Jonathan W Riess | Author(s): Karen L Reckamp, J. Longmate, Karen Kelly, David R. Gandara, Philip Christopher Mack, E. Newman, Primo Lara
- Abstract
Loading...
-
+
MA 05 - Immuno-Oncology: Novel Biomarker Candidates
- 15:45 - 17:30
- 10/16/2017
- Location: Room 303 + 304
- Type: Mini Oral
- Track: Immunology and Immunotherapy
- Moderators:Yoichi Nakanishi, P. Mitchell
-
+
MA 05.09 - Pre-Existing Immunity Measured by Teff Gene Expression in Tumor Tissue is Associated with Atezolizumad Efficacy in NSCLC
16:35 - 16:40 | Presenter: Marcin Kowanetz | Author(s): W. Zou, M. McCleland, David R. Gandara, Shirish M Gadgeel, A. Rittmeyer, Fabrice Barlesi, Keunchil Park, D.S. Shames, H. Koeppen, M. Ballinger, A. Sandler, P. Hegde
- Abstract
Loading...
-
+
MS 05 - Clinical Issues of Immune Checkpoint Inhibitors
- 15:45 - 17:30
- 10/16/2017
- Location: Main Hall
- Type: Mini Symposium
- Track: Immunology and Immunotherapy
- Moderators:Luis E Raez, Nico Van Zandwijk
-
+
MS 05.05 - Continuation of Immunotherapy in Post-Progressive Disease
16:45 - 17:00 | Presenter: David R. Gandara
- Abstract
No abstract available for this presentation
-
+
MA 07 - ALK, ROS and HER2
- 15:45 - 17:30
- 10/17/2017
- Location: Room 316
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Robert C. Doebele, J.C. Ho
-
+
MA 07.14 - Change in Practice Patterns from an Online NSCLC Treatment Decision Support Tool
17:10 - 17:15 | Presenter: David R. Gandara
- Abstract
No abstract available for this presentation
-
+
MA 13 - New Insights of Diagnosis and Update of Treatment
- 15:45 - 17:30
- 10/17/2017
- Location: Room 311 + 312
- Type: Mini Oral
- Track: Early Stage NSCLC
- Moderators:S. Ishikura, H. Nakayama
-
+
MA 13.02 - Comprehensive Genetic Analysis Related to PD-L1 Expression in Early-stage Lung Squamous Cell Carcinoma
15:50 - 15:55 | Presenter: Hui Yu | Author(s): Z. Chen, K. Ballman, M. Watson, Ramaswamy Govindan, D. Beer, Raphael Bueno, L. Chirieac, M.H. Chui, W.A. Franklin, David R. Gandara, C. Genova, M. Joshi, D.T. Merrick, W.G. Richards, C.J. Rivard, Frances A Shepherd, T. Sporn, Ming Sound Tsao, K. Brovsky, A.V. Bokhoven, David Harpole, Fred R. Hirsch
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-046 - Longitudinal Analysis of Plasma CtDNA in EGFR-Mutant NSCLC: SWOG S1403 Trial of Afatinib with or Without Cetuximab
09:30 - 09:30 | Presenter: Philip Christopher Mack | Author(s): J. Miao, K.C. Banks, R.A. Burich, K. Politi, V.M. Raymond, D. Dix, R.B. Lanman, J. Moon, M.A.C. Melnick, A. Truini, Mary Redman, S.B. Goldberg, David R. Gandara, Karen Kelly
- Abstract
Loading...
-
+
OA 12 - Emerging Genomic Targets
- 11:00 - 12:30
- 10/18/2017
- Location: F203 + F204 (Annex Hall)
- Type: Oral
- Track: Advanced NSCLC
- Moderators:H. Akita, Maurice Pérol
-
+
OA 12.05 - Spectrum of 1,014 Somatic BRAF Alterations Detected in Cell-Free DNA of Patients with Advanced Non-Small Cell Lung Cancer
11:40 - 11:50 | Presenter: Trever G Bivona | Author(s): V.M. Raymond, R.B. Lanman, R.J. Nagy, K.C. Banks, Y.K. Chae, J.M. Clarke, Jeffrey Crawford, David R. Gandara, John V Heymach
- Abstract
Loading...
-
+
OA 14 - New Paradigms in Clinical Trials
- 11:00 - 12:30
- 10/18/2017
- Location: Room 311 + 312
- Type: Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Alex Adjei, Eun Kyung Cho
-
+
OA 14.07 - Progress in Lung Squamous Cell Carcinoma from the Lung-MAP Master Protocol (S1400) Sub-Studies S1400A, S1400B, S1400C and S1400D
12:05 - 12:15 | Presenter: Roy S. Herbst | Author(s): Mary Redman, David R. Gandara, Fred R. Hirsch, Philip Christopher Mack, Hossein Borghaei, Corey J Langer, J. Wade, J.A. Engelman, Martin Edelman, K. Albain, Primo Lara, C. Aggarwal, M.A. Socinski, Scott N. Gettinger, Lyudmila Bazhenova, S.N. Waqar, Francisco Robert, G.J. Kiefer, Jeffrey Bradley, Jeffrey Crawford, E. McGary, N.M. Rafique, D. Petro, P.C. Hoffman, Y. Zhou, J. Miao, K. Griffin, S. McDonough, C. Miwa, S. Malik, V.A. Miller, E.V. Sigal, S. Adam, C.D. Blanke, Karen Kelly, Vassiliki A Papadimitrakopoulou
- Abstract
Loading...
-
+
OA 17 - Immunotherapy II
- 14:30 - 16:15
- 10/18/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Immunology and Immunotherapy
- Moderators:Yuichiro Ohe, Anne Tsao
-
+
OA 17.07 - Long-Term Survival in Atezolizumab-Treated Patients with 2L+ NSCLC from Ph III Randomized OAK Study
15:35 - 15:45 | Presenter: Miyako Satouchi | Author(s): L. Fehrenbacher, Manuel Cobo Dols, Ji-Youn Han, J. Von Pawel, R. Bordoni, T. Hida, Keunchil Park, D. Moro-Sibilot, P. Conkling, C. Matheny, W. Yu, P. He, Marcin Kowanetz, M. Gandhi, M. Ballinger, A. Sandler, David R. Gandara
- Abstract
Loading...